Clinical trial
24-hr Intraocular Pressure Control With Brinzolamide 1% / Brimonidine 0.2% Ophthalmic Suspension vs Vehicle
NCT02770248 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 24-hr Intraocular Pressure Control With Brinzolamide 1% / Brimonidine 0.2% Ophthalmic Suspension vs Vehicle
- Lead sponsor
- Alcon Research
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 23, 2016
- Completion date
- January 14, 2017
- Enrollment
- 162 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.